非洲围产期HIV感染儿童长期cART中未抑制病毒血症与低CD4计数与端粒加速损耗相关
该研究基于VITALITY试验队列,纳入赞比亚和津巴布韦11-19岁围产期HIV感染儿童842例,分析HIV病毒载量与CD4计数和端粒长度及其损耗率的关系。结果显示病毒载量>1000 copies/mL与较短端粒长度及加速端粒损耗相关,低CD4计数亦与端粒加速损耗相关。
要点
- 病毒载量>1000 copies/mL与儿童端粒长度缩短独立相关。
- 基线CD4计数每降低100 cells/μL,端粒长度缩短且损耗加速。
- 持续病毒载量>1000 copies/mL者在约1年内端粒加速损耗。
核心结论
- 在非洲长期cART的围产期HIV感染儿童中,HIV病毒载量>1000 copies/mL与1年内免疫年龄退化相关,可能增加远期合并症风险。
研究设计与样本
- VITALITY试验队列研究,基线纳入842例11-19岁围产期HIV感染儿童,纵向分析纳入783例,中位随访336±6天。
主要发现
- 基线时678例(80.5%)病毒载量<60 copies/mL,66例(7.8%)为60-1000 copies/mL,98例(11.6%)>1000 copies/mL。
- 相比病毒载量<60 copies/mL者,>1000 copies/mL者端粒长度更短(β=-.239,95%CI -.451至-.026,P=.028)。
- 较低CD4计数与较短端粒长度相关(每100 cells/μL β=-.038,95%CI -.009至-.066,P=.009)。
- 两个时间点病毒载量均>1000 copies/mL者端粒损耗加速(β=-.276,95%CI -.546至-.005,P=.046)。
- 较低基线CD4计数与更快速端粒损耗相关(β=-.033,95%CI -.008至-.057,P=.009)。
临床怎么用
- 对长期cART的围产期HIV感染儿童,维持病毒载量<1000 copies/mL可能有助于减缓免疫老化。
- 监测CD4计数有助于识别端粒加速损耗高风险儿童。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Human immunodeficiency virus (HIV-1) infection leads to reduced telomere length (TL), a biomarker of immune aging. We investigated relationships between HIV viral load (VL) and CD4 count with TL and its rate of attrition in children with HIV from Zambia and Zimbabwe. METHODS: Buffy coat was obtained at baseline and 48 weeks from children aged 11-19 years with perinatally acquired HIV taking combination antiretroviral therapy (cART) for >6 months recruited into the VITALITY trial. Relative TL was measured using monochrome multiplex quantitative polymerase chain reaction, standardizing units for analysis. Cross-sectional analyses used multivariable linear regression adjusting for age, sex, and study site; longitudinal analysis additionally adjusted for baseline TL. RESULTS: Among participants at baseline (N = 842; mean ± SD age, 15.5 ± 2.6 years; 53.2% female), 678 (80.5%) had HIV VL <60 copies/mL, 66 (7.8%) had 60-1000 copies/mL, and 98 (11.6%) had >1000 copies/mL. The mean CD4 count was 584 ± 243 cells/μL. Compared to participants with VL <60 copies/mL, those with VL >1000 copies/mL had shorter TL (β = -.239 [95% confidence interval {CI}, -.451 to -.026]; P = .028), whereas those with 60-1000 copies/mL did not (P = .836). Lower CD4 cell count was associated with shorter TL (β = -.038 [95% CI, -.009 to -.066] per 100 CD4 cells/μL; P = .009). In longitudinal analysis (n = 783) after mean 336 ± 6 days, those with HIV VL >1000 copies/mL at both timepoints had an accelerated telomere attrition rate (β = -.276 [95% CI, -.546 to -.005]; P = .046) compared with participants with VL <1000 copies/mL. Lower baseline CD4 count was associated with faster telomere attrition rate (β = -.033 [95% CI, -.008 to -.057]; P = .009). CONCLUSIONS: HIV VL >1000 copies/mL among children with HIV on cART in Africa is associated with a degradation of immune age within 1 year, which may increase risk of comorbidities later in life. CLINICAL TRIALS REGISTRATION: PACTR202009897660297.
引用
- Shellard JPG, Carr E, Tam-McMillan G, et al. Unsuppressed Viremia and Lower CD4 Count Associated With Faster Telomere Attrition in African Children With Perinatal Human Immunodeficiency Virus on Long-term Antiretroviral Therapy. J Infect Dis. 2026. PMID: 41655979. doi:10.1093/infdis/jiag060
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。